Clinical
BSPED Endorsed Guidelines
The guidelines included on this page have been endorsed by the BSPED and reflect the Society's views on best practice for the average patient. Each patient must be considered as an individual in the context of their condition and other medication, and whilst every effort has been made to ensure the factual accuracy of the contents no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines, which is solely at the discretion of the reader.
An endorsed guideline is one that has been commissioned by the BSPED. All other guidelines listed on this site are BSPED supported guidelines.
Endocrine Guidelines
 |
Paediatric Rare Endocrine Tumours (pdf) (3.15mb) | Oct 2005 |
|
Shared care guidelines: Treatment of Children with Recombinant Human Growth Hormone (r-hGH) (pdf) (72kb) | April 2006 |
Diabetes Guidelines
